riccardo dolcetti
Peter MacCallum Cancer Centre
Melbourne, Australia
Associate Editor
Cancer Immunity and Immunotherapy
Peter MacCallum Cancer Centre
Melbourne, Australia
Associate Editor
Cancer Immunity and Immunotherapy
Medical University of South Carolina
Charleston, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
Children’s National Hospital
Washington D.C., United States
Associate Editor
Pediatric Oncology
David Geffen School of Medicine, University of California, Los Angeles
Los Angeles, United States
Associate Editor
Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Institut Jules Bordet, Université libre de Bruxelles
Anderlecht, Belgium
Associate Editor
Surgical Oncology
College of Medicine and Science, Mayo Clinic
Rochester, United States
Associate Editor
Cancer Immunity and Immunotherapy
University of Nebraska Medical Center
Omaha, United States
Associate Editor
Molecular and Cellular Oncology
University of British Columbia
Vancouver, Canada
Associate Editor
Cancer Molecular Targets and Therapeutics
The Ohio State University
Columbus, United States
Associate Editor
Cancer Immunity and Immunotherapy
Southwest University
Chongqing, China
Associate Editor
Gastrointestinal Cancers: Colorectal Cancer
Capital Health
Pennington, United States
Associate Editor
Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
School of Pharmacy, Liaoning University of Traditional Chinese Medicine
Da Lian, China
Associate Editor
Pharmacology of Anti-Cancer Drugs
School of Medicine, Southeast University
Nanjing, China
Associate Editor
Molecular and Cellular Oncology
Erasmus Medical Center
Rotterdam, Netherlands
Associate Editor
Cancer Immunity and Immunotherapy
University of Pittsburgh
Pittsburgh, United States
Associate Editor
Neuro-Oncology and Neurosurgical Oncology
University of North Carolina at Charlotte
Charlotte, United States
Associate Editor
Molecular and Cellular Oncology